Ronidazole

Ronidazole is a potent and orally active antiprotozoal and anti-microbial agent. Ronidazole acts as a veterinary agent against Tritrichomonas foetus in cats models. Ronidazole can be used the research of forhistomoniasis and swine dysentery[1][2][3].

Product Specifications

CAS Number

[7681-76-7]

UNSPSC

12352005

Hazard Statement

H302

Target

Bacterial; Parasite

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/Ronidazole.html

Purity

99.48

Solubility

DMSO : 100 mg/mL (ultrasonic) |H2O : 4 mg/mL (ultrasonic)

Smiles

NC(OCC1=NC=C([N+]([O-])=O)N1C)=O

Molecular Formula

C6H8N4O4

Molecular Weight

200.15

Precautions

H302

References & Citations

[1]Jody L Gookin, et al. Efficacy of ronidazole for treatment of feline Tritrichomonas foetus infection. J Vet Intern Med|[2]AbdelKhalek A, et al. Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection. Int J Antimicrob Agents. 2020;56 (6) :106188.|[3]LeVine DN, et al. Ronidazole pharmacokinetics after intravenous and oral immediate-release capsule administration in healthy cats. J Feline Med Surg. 2011;13 (4) :244-250.